Portal de Periódicos da CAPES

ACUTE PROMYELOCYTIC LEUKAEMIA

1992; Wiley; Volume: 81; Issue: 3 Linguagem: Romeno

10.1111/j.1365-2141.1992.tb08233.x

1365-2141

Giuseppe Avvisati, Jan W. ten Cate, Franco Mandelli,

Nuclear Structure and Function

British Journal of HaematologyVolume 81, Issue 3 p. 315-320 ACUTE PROMYELOCYTIC LEUKAEMIA Giuseppe Avvisati, Corresponding Author Giuseppe Avvisati Haematology, Department of Human Biopathology, University ‘La Sapienza’, Rome, ItalyDr Giuseppe Avvisati, Haematology, Department of Human Biopathology, Via Benevento 6, I-00161 Roma, Italy.Search for more papers by this authorJan Wouter ten Cate, Jan Wouter ten Cate Centre of Haemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, Amsterdam, The NetherlandsSearch for more papers by this authorFranco Mandelli, Franco Mandelli Haematology, Department of Human Biopathology, University ‘La Sapienza’, Rome, ItalySearch for more papers by this author Giuseppe Avvisati, Corresponding Author Giuseppe Avvisati Haematology, Department of Human Biopathology, University ‘La Sapienza’, Rome, ItalyDr Giuseppe Avvisati, Haematology, Department of Human Biopathology, Via Benevento 6, I-00161 Roma, Italy.Search for more papers by this authorJan Wouter ten Cate, Jan Wouter ten Cate Centre of Haemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Centre, Amsterdam, The NetherlandsSearch for more papers by this authorFranco Mandelli, Franco Mandelli Haematology, Department of Human Biopathology, University ‘La Sapienza’, Rome, ItalySearch for more papers by this author First published: July 1992 https://doi.org/10.1111/j.1365-2141.1992.tb08233.xCitations: 32AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Ahmed, N., Williams, J.F. & Weidemann, M.J. (1991) The human promyelocytic HL60 cell line. A model of myeloid cell differentiation using dimethylsulfoxide, phorbolester and butyrate. Biochemistry International, 23, 591–602. CASPubMedWeb of Science®Google Scholar Alcalay, N., Zangrilli, D., Pandolfi, P.P., Longo, L., Mencarelli, A., Giacomucci, A., Rocchi, M., Biondi, A., Rambaldi, A., Lo Coco, F., Diverio, D., Donti, E., Grignani, F. & Pelicci, P.G. (1991) Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proceedings of the National Academy of Sciences of the United States of America, 88, 1977–1981. 10.1073/pnas.88.5.1977 CASPubMedWeb of Science®Google Scholar Avvisati, G., ten Cate, J.W. & Mandelli, F. (1987) The coagulopathy in acute promyelocytic leukaemia: DIC. Hemostasis and Cancer (ed. by L. Muszbek), pp. 91–100. CRC Press, Boca Raton , Florida . Google Scholar Avvisati, G., ten Cate, J.W., Sturk, A., Lamping, R., Petti, M.C. & Mandelli, F. (1988) Acquired alpha 2-antiplasmin deficiency in acute promyelocytic leukaemia. British Journal of Haematology, 70, 43–48. 10.1111/j.1365-2141.1988.tb02432.x PubMedWeb of Science®Google Scholar Avvisati, G., ten Cate, J.W., Büller, H. & Mandelli, F. (1989) Efficacy of tranexamic acid in controlling haemorrhage in patients with acute promyelocytic leukaemia: a placebo controlled study. Lancet, ii, 122–124. 10.1016/S0140-6736(89)90181-5 CASGoogle Scholar Avvisati, G., Mandelli, F., Petti, M.C., Vegna, M.L., Spadea, A., Liso, V., Specchia, G., Bernasconi, C., Alessandrino, E.P., Piatti, C. & Carella, A.M. (1990) Idarubicin (4-demethoxidaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukaemia. A pilot study of the Italian cooperative group GIMEMA. European Journal of Haematology, 44, 257–260. 10.1111/j.1600-0609.1990.tb00389.x CASPubMedWeb of Science®Google Scholar Avvisati, G., Mele, A., Stazi, M.A., Vegna, M.L., Pasquini, P. & Mandelli, F. (1991a) Epidemiology of acute promyelocytic leukaemia in Italy. Annals of Oncology, 2, 405–408. CASPubMedWeb of Science®Google Scholar Avvisati, G., Petti, M.C., Spadea, A., Leone, G., Sica, S., Liso, V., Specchia, G., Carotenuto, M., Leoni, P., Papa, G., Resegotti, L., Rotoli, B. & Mandelli, F. (1991b) All-trans retinoic acid (RA) in poor risk acute promyelocytic leukaemia (APL): a pilot study of the Italian cooperative group GIMEMA. Haematologica, 76 (Supplement 4), 16 (Abstract 56). Google Scholar Bennett, B., Booth, N.A., Croll, A. & Dawson, A. (1989) The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. British Journal of Haematology, 71, 511–517. 10.1111/j.1365-2141.1989.tb06311.x PubMedWeb of Science®Google Scholar Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1976a) Proposal for the classification of the acute leukaemias. French–American–British (FAB) Cooperative Group. British Journal of Haematology, 33, 451–458. 10.1111/j.1365-2141.1976.tb03563.x CASPubMedWeb of Science®Google Scholar Bennett, M., Parker, A.C. & Ludlam, C.A. (1976b) Platelet and fibrinogen survival in acute promyelocytic leukaemia. British Medical Journal, ii, 565. 10.1136/bmj.2.6035.565 CASGoogle Scholar Biondi, A., Rambaldi, A., Alcalay, M., Pandolfi, P.P., Lo Coco, F., Diverio, D., Rossi, V., Mencarelli, A., Longo, L., Zangrilli, D., Masera, G., Barbui, T., Mandelli, F., Grignani, F. & Pelicci, P.G. (1991) RAR-a rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood, 77, 1418–1422. CASPubMedWeb of Science®Google Scholar Bloomfield, C.D., Trent, J.M. & van den Berghe, H. (1987) Report of the committee on structural chromosome changes in neoplasia. Ninth International Workshop on Human Gene Mapping. (Paris Conference). Cytogenetics and Cell Genetics, 46, 344–369. 10.1159/000132485 CASPubMedWeb of Science®Google Scholar Borrow, J., Goddard, A.D., Sheer, D. & Solomon, E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249, 1577–1579. 10.1126/science.2218500 CASPubMedWeb of Science®Google Scholar Bratt, G., Blombäck, M., Paul, C., Shulman, S., Törnebohn, E. & Lockner, D. (1985) Factors and inhibitors of blood coagulation and fibronolysis in acute non-lymphoblastic leukaemia. Scandinavian Journal of Haematology, 34, 332–339. 10.1111/j.1600-0609.1985.tb00758.x CASPubMedWeb of Science®Google Scholar Castaigne, S., Chomienne, C., Daniel, M.T., Ballerini, P., Berger, R., Fenaux, P. & Degos, L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76, 1704–1709. 10.1182/blood.V76.9.1704.1704 CASPubMedWeb of Science®Google Scholar Champlin, R. & Gale, R.P. (1987) Acute myelogenous leukemia. Recent advances in therapy. Blood, 69, 1551–1562. PubMedWeb of Science®Google Scholar Chan, T.K., Chan, G.T.C. & Chan, V. (1984) Hypofibrinogenaemia due to increased fibrinolysis in two patients with acute promyelocytic leukaemia. Australian and New Zealand Journal of Medicine, 14, 245–249. 10.1111/j.1445-5994.1984.tb03760.x CASPubMedWeb of Science®Google Scholar Chen, Z.X., Xue, Y.Q., Zhang, R., Tao, R.F., Xia, X.M., Li, C., Wang, W., Zu, W.Y., Yao, X.Z. & Ling, B.J. (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood, 78, 1413–1419. 10.1182/blood.V78.6.1413.1413 CASPubMedWeb of Science®Google Scholar Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M.T., Castaigne, S. & Degos, L. (1990) All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure–function relationship. Blood, 76, 1710–1717. PubMedWeb of Science®Google Scholar De Rossi, G., Avvisati, G., Coluzzi, S., Fenu, S., Lo Coco, F., Lopez, M., Nanni, M., Pasqualetti, D. & Mandelli, F. (1990) Immunological definition of acute promyelocytic leukaemia (FAB M3): a study of 39 cases. European Journal of Haematology, 67, 168–171. Google Scholar de Thè, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature, 347, 558–561. 10.1038/347558a0 CASPubMedWeb of Science®Google Scholar de Thè, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. & Dejean, A. (1991) The PML-RARa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukaemia encodes a functionally altered RAR. Cell, 66, 675–684. 10.1016/0092-8674(91)90113-D CASPubMedWeb of Science®Google Scholar Goldberg, M.A., Ginsburg, D., Mayer, R.J., Stone, M.R., Maguire, M., Rosenthal, D.S. & Antin, J.H. (1987) Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia Blood, 69, 187–191. CASPubMedWeb of Science®Google Scholar Golomb, H.M., Rowley, J.D., Vardiman, J., Baron, J., Locker, G. & Krasnow, S. (1976) Partial deletion of long arm of chromosome 17. A specific abnormality in acute promyelocytic leukaemia Archives of Internal Medicine, 136, 825–828. CASPubMedWeb of Science®Google Scholar Gouault-Heilmann, M., Chardon, E., Sultan, C. & Josso, F. (1975) The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor. British Journal of Haematology, 30, 151–158. 10.1111/j.1365-2141.1975.tb00529.x CASPubMedWeb of Science®Google Scholar Gralnick, H.R. & Abrell, E. (1973) Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. British Journal of Haematology, 24, 89–99. 10.1111/j.1365-2141.1973.tb05730.x CASPubMedWeb of Science®Google Scholar Huang, M.E., Ye, H.C., Chen, S.R., Chai, J.R., Lu, H.X., Zoha, L., Gu, L.J. & Wang, Z.I. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567–572. 10.1182/blood.V72.2.567.567 CASPubMedWeb of Science®Google Scholar Kahlé, L.H., Avvisati, G., Lamping, R.J., Moretti, T., Mandelli, F. & ten Cate, J.W. (1985) Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukaemia. Scandinavian Journal of Clinical and Laboratory Investigation, 45, (Suppl. 178), 75–80. Google Scholar Kakizuka, A., Miller, W.H., Jr. Umesono, K., Warrell, R.P., Jr. Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E. & Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor. PML. Cell, 66, 663–674. 10.1016/0092-8674(91)90112-C CASPubMedWeb of Science®Google Scholar Kantarjian, H.M., Keating, M.J., Walters, R.S., Estey, E.H., McCredie, K.B., Smith, T., Dalton, W., Cork, A., Trujillo, J.M. & Freireich, E.J. (1986) Acute promyelocytic leukemia. M.D. Anderson Hospital experience. American Journal of Medicine, 80, 789–797. 10.1016/0002-9343(86)90617-0 CASPubMedWeb of Science®Google Scholar Kantarjian, H.M., Keating, M.J., Walters, R.S., Smith, T.L., McCredie, K.B. & Freireich, E.J. (1987) Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer, 59, 1258–1263. 10.1002/1097-0142(19870401)59:7 3.0.CO;2-G CASPubMedWeb of Science®Google Scholar Koeffler, H.P. (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 62, 709–721. PubMedWeb of Science®Google Scholar Krause, J.R., Stolen, V., Kaplan, S.S. & Penchansky, L. (1989) Microgranular promyelocytic leukemia: a multiparameter examination. American Journal of Hematology, 30, 158–163. 10.1002/ajh.2830300308 CASPubMedWeb of Science®Google Scholar Lichtman, M.A. & Henderson, E.S. (1990) Acute myelogenous leukemia. Hematology (ed. by W. J. Williams, E. Beutler, A. J. Erslev and M. A. Lichtman), pp. 252–272. McGraw-Hill, New York . Google Scholar Lo Coco, F., Avvisati, G., Diverio, D., Petti, M.C., Alcalay, M., Pandolfi, P.P., Zangrilli, D., Biondi, A., Rambaldi, A., Moleti, M.R., Mandelli, F. & Pelicci, P.G. (1991a) Molecular evaluation of all-transretinoic acid therapy in patients with acute promyelocytic leukemia. Blood, 77, 1657–1659. CASPubMedWeb of Science®Google Scholar Lo Coco, F., Avvisati, G., Diverio, D., Biondi, A., Pandolfi, P.P., Alcalay, M., De Rossi, G., Petti, M.C., Cantü-Rajnoldi, A., Pasqualetti, D., Nanni, M., Fenu, S., Frontani, M. & Mandelli, F. (1991b) Rearrangements of the RAR-α gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype. British Journal of Haematology, 78, 494–499. 10.1111/j.1365-2141.1991.tb04478.x CASPubMedWeb of Science®Google Scholar Longo, L., Pandolfi, P.P., Biondi, A., Rambaldi, A., Mencarelli, A., Lo Coco, F., Diverio, D., Pegoraro, L., Avanzi, G., Tabilio, A., Donti, E., Grignani, F. & Pelicci, P.G. (1990) Rearrangements and aberrant expression of the retinoic acid receptor α gene in acute promyelocytic leukemias. Journal of Experimental Medicine, 172, 1571–1575. 10.1084/jem.172.6.1571 CASPubMedWeb of Science®Google Scholar Marty, M., Ganem, G., Fischer, J., Flandrin, G., Berger, R., Schaison, G., Degos, L. & Borion, M. (1984) Leucémie aiguë promyélocitaire: étude retrospective de 119 malades traités par daunorubicine. Nouvelle Revue Française d'Hématologie, 26, 371–378. CASPubMedWeb of Science®Google Scholar Misawa, S., Lee, E., Schiffer, C.A., Liu, Z. & Testa, J.R. (1986) Association of the translocation (15;17) with malignant proliferation of promyelocytes in acute leukemia and chronic myelogenous leukemia at blastic crisis. Blood, 67, 270–274. CASPubMedWeb of Science®Google Scholar Moir, D.J., Pearson, J.H. & Buckle, V.J. (1984) Acute promyelocytic transformation in a case of chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics, 12, 359. 10.1016/0165-4608(84)90069-4 CASPubMedWeb of Science®Google Scholar Nakamaki, T., Sakashita, A., Sano, M., Hino, K., Suzuki, K., Tomoyatsu, S., Tsuruoka, N., Honma, Y. & Hozumi, M. (1989) Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cell in vitro. Japanese Journal of Cancer Research, 80, 1077–1082. 10.1111/j.1349-7006.1989.tb02262.x CASPubMedWeb of Science®Google Scholar Petti, M.C., Avvisati, G., Amadori, S., Baccarini, M., Guarini, A.R., Papa, G., Rosti, G.A., Tura, S. & Mandelli, F. (1987) Acute promyelocytic leukaemia: clinical aspects and results of treatment in 62 patients. Haematologica, 72, 151–155. CASPubMedWeb of Science®Google Scholar Pébusque, M.J., Lafage, M., Lopez, M. & Mannoni, P. (1988) Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony-stimulating factor. Blood, 72, 257–265. CASPubMedWeb of Science®Google Scholar Rodeghiero, F., Avvisati, G., Castaman, G., Barbui, T. & Mandelli, F. (1990) Early deaths and antihemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood, 75, 2112–2117. CASPubMedWeb of Science®Google Scholar Rowley, J.D., Golomb, H.M. & Dougherty, C. (1977) (15;17) translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet, i, 549–550. 10.1016/S0140-6736(77)91415-5 CASGoogle Scholar San Miguel, J.F., Gonzales, M., Cañizo, M.C., Auta, J.P., Zola, H. & Lopez-Borrasca, A. (1986) Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. British Journal of Haematology, 64, 547–560. 10.1111/j.1365-2141.1986.tb02211.x PubMedWeb of Science®Google Scholar Sanz, M.A., Jarque, I., Martin, G., Lorenzo, I., Martinez, J., Rafecas, J., Pastor, E., Sayas, M.J., Sanz, G. & Gomis, F. (1988) Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer, 61, 7–13. 10.1002/1097-0142(19880101)61:1 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar Stone, R.M., Maguire, M., Goldberg, M.A., Antin, J.H., Rosenthal, D.S. & Mayer, R.J. (1988) Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients. Blood, 71, 690–696. CASPubMedWeb of Science®Google Scholar Stone, R.M. & Mayer, R.J. (1990) The uniques aspects of acute promyelocytic leukaemia. Journal of Clinical Oncology, 8, 1913–1921. 10.1200/JCO.1990.8.11.1913 PubMedWeb of Science®Google Scholar Takahashi, H., Tatewaki, W., Wada, K., Niwano, H. & Shibata, A. (1990) Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation. Thrombosis and Haemostasis, 63, 340–344. CASPubMedWeb of Science®Google Scholar Velasco, F., Torres, A., Andres, P., Martinez, F. & Gomez, P. (1984) Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukaemia. Thrombosis and Haemostasis, 52, 81–84. CASPubMedWeb of Science®Google Scholar Warrell, R.P., Frankel, S.R., Miller, W.H., Jr. Scheinberg, D.A., Itri, L.M., Hittelman, W.N., Vyas, R., Andreef, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M.S. & Dimitrowski, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England Journal of Medicine, 324, 1385–1393. 10.1056/NEJM199105163242002 PubMedWeb of Science®Google Scholar Wiernik, P.H. (1990) Acute promyelocytic leukemia: another pseudoleukemia Blood, 76, 1675–1677. CASPubMedWeb of Science®Google Scholar Citing Literature Volume81, Issue3July 1992Pages 315-320 ReferencesRelatedInformation